Diindolylmethane Market

Diindolylmethane Market Snapshot

The global diindolylmethane market size is expected to reach US$ 7.1 Billion in 2032 and exhibit considerable growth at a CAGR of 2.9% in the forecast period from 2022 to 2032. The rising popularity of plant-based natural ingredients worldwide is anticipated to bode well for the market. As per Future Market Insights (FMI), the market is likely to be valued at US$ 4.8 Billion in 2022.

Diindolylmethane is considered to be a natural substance formed in the human body by consuming cruciferous vegetables, such as kale, cauliflower, brussels sprouts, cabbage, and broccoli. It is generated through the acid-catalyzed reaction of indole-3-carbinol.

The extensive usage of diindolylmethane to prevent colorectal, breast, and uterine cancers is anticipated to augment the market. It is also utilized for the treatment of premenstrual syndrome and enlarged prostate.

In addition to that, diindolylmethane is capable of improving and supporting the process of estrogen breakdown by the liver. It also aids in surging the conversion of estrogen of significant metabolites. At the same time, it acts as an aromatase inhibitor to prevent the conversion of testosterone into estrogen.

How is Health Supplement Consumption Driving the Diindolylmethane Market Growth

The rising consumption of various health supplements among people to maintain a healthy balance of testosterone in their body is estimated to push sales of diindolylmethane in the global market. Diindolylmethane does not affect the overall testosterone levels while supporting the same.

It possesses multiple properties, such as hormone-balancing, antibacterial, anti-inflammatory, and antiviral, which is also set to drive their demand in future. The increasing usage of diindolylmethane as a therapeutic drug for the treatment of infectious diseases, immune deficiencies, and cancer is another vital factor that is likely to augment growth.

Which Factors Are Expected to Hamper the Diindolylmethane Market Growth

Some of the most common side effects of diindolylmethane include diarrhea, gas, vomiting, nausea, and headache. In some people, the consumption of 600 mg of diindolylmethane every day can lower their sodium levels to a certain extent. These factors may hamper the demand for diindolylmethane in the upcoming years.

Why is the North America Diindolylmethane Market Exhibiting Rapid Growth

North America is likely to account for the largest diindolylmethane market share in the evaluation period. The presence of various well-established health supplement manufacturers across the U.S. and Canada is anticipated to accelerate the regional market.

The increasing prevalence of breast cancer and uterine cancer in these developed countries is another crucial factor that is set to spur the market. As per the Centers for Disease Control and Prevention (CDC), in 2018, around 254,744 new cases of breast cancer were registered in the U.S. alone. This number is expected to grow at a fast pace in future years, thereby driving the North America market.

Nandini Roy Choudhury

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

How are Rising Cases of Obesity Pushing the Europe Diindolylmethane Market

Europe is projected to showcase a steady diindolylmethane market growth in the assessment period. This growth is attributable to the rising purchasing power of consumers and increasing government investments in the development of healthcare infrastructure across the U.K., Italy, and Germany.

The rising cases of obesity owing to the rapid adoption of sedentary lifestyle are also anticipated to contribute to this growth. According to the U.K. Parliament, approximately 28.0% of adults are obese in England, while 36.2% of people are overweight. This trend is likely to continue throughout the forthcoming years, thereby propelling the Europe market.

Market Competition

Some of the leading players operating in the global diindolylmethane market include VitaSolutions, Now Health Group, Inc., Genestra Brands, Source Naturals, BioResponse Nutrients, Nature’s Way, Nutri Advanced Ltd., SD Pharmaceuticals, Solaray, Nutricost, Pure Organics, Pure Bulk, Jarrow Naturals, and Adrana LLC among others.

Majority of the key players are focusing on adopting various marketing strategies to increase sales of their in-house products. They are offering their products with several claims, such as soy-free, egg-free, non-GMO, nut-free, corn-free, and organic labels. A few other companies are engaging in the development of relatively low cost health supplements infused with diindolylmethane to target the middle-class population.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Sign-Up

Report Scope

Key Segments Profiled in the Diindolylmethane Industry Survey

By Form:

• Dry
• Liquid

By Nature:

• Organic
• Conventional

By Source:

• Broccoli
• Kale
• Cauliflower
• Others

By Region:

• North America
• Latin America
• Western Europe
• Eastern Europe
• APEJ
• Japan
• Middle East and Africa